Skip to main content
Equibles

Bank of New York Mellon Corp

Bank

Position in XFOR — X4 Pharmaceuticals, Inc

CIK 1390777 NEW YORK, NY
Back to XFOR Full portfolio

Position in XFOR

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$916,907
+$835,548 QoQ
Shares Held
196,340
+1608.5% QoQ
Ownership
0.198%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#30
of 89 holders
Holding Since
Mar 2020
19 quarters on record
Voting authority Sole 86% Shared 0% None 14%

Common Shares in XFOR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Bank of New York Mellon Corp holds $4,864,365,655 across 311 Biotechnology names. XFOR ranks #197 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,672,623 $830,842,010
2 REGN
Regeneron Pharmaceuticals, Inc.
 758,492 $472,950,091
3 JAZZ
Jazz Pharmaceuticals plc
 1,578,013 $380,253,782
4 ALNY
Alnylam Pharmaceuticals, Inc.
 492,071 $148,128,128
5 INSM
INSMED Inc
 1,312,756 $139,966,036
6 MRNA
Moderna, Inc.
 1,701,675 $119,168,293
7 RVMD
Revolution Medicines, Inc.
 601,056 $112,565,759
8 INCY
Incyte Corp
 972,825 $110,279,435

All Filings in XFOR

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $916,907 196,340
2025-03-31 $81,359 344,747
2024-12-31 $253,043 344,747
2024-09-30 $230,634 344,747
2024-06-30 $272,234 469,372
2024-03-31 $467,002 335,974
2023-12-31 $290,254 345,954
2023-09-30 $517,414 474,693
2023-06-30 $927,763 478,229
2023-03-31 $148,937 171,193
2022-12-31 $169,994 171,193
2022-09-30 $238,880 139,696
2022-06-30 $134,806 139,696
2022-03-31 $246,070 140,612
2021-03-31 $468,082 54,365
2020-12-31 $336,288 52,300
2020-09-30 $332,765 49,153
2020-06-30 $446,436 47,901
2020-03-31 $389,317 38,932